Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Swiss Re AG ( (CH:SREN) ).
Swiss Re reported a record 2025 net profit of USD 4.8 billion, up 47% and above its target, driven by strong underwriting in property and casualty lines, lower-than-expected natural catastrophe losses and solid investment returns. The group posted a 19.6% return on equity, a 4.0% investment return and maintained a robust Swiss Solvency Test ratio of about 250%, while P&C Re and Corporate Solutions both met or beat combined ratio targets despite slightly lower insurance revenues.
The company plans to return substantial capital to shareholders via a proposed 9% dividend increase to USD 8.00 per share and a share buyback of up to USD 1.5 billion in 2026, including a USD 500 million sustainable annual programme. Management highlighted that the completion of a portfolio review at Life & Health Re, the exit from the iptiQ business and disciplined renewals in a tougher market should enhance resilience and position all three business units for more consistent earnings, while Board changes include the proposed election of Jean‑Jacques Henchoz and the departure of Larry Zimpleman.
The most recent analyst rating on (CH:SREN) stock is a Sell with a CHF119.00 price target. To see the full list of analyst forecasts on Swiss Re AG stock, see the CH:SREN Stock Forecast page.
More about Swiss Re AG
Swiss Re is a leading global reinsurance company based in Zurich, operating across property and casualty, life and health reinsurance, and corporate insurance solutions. It focuses on disciplined underwriting, capital strength and investment performance to support insurers and large corporates worldwide, with an emphasis on managing natural catastrophe and longevity risks.
Average Trading Volume: 876,561
Technical Sentiment Signal: Buy
Current Market Cap: CHF35.4B
For detailed information about SREN stock, go to TipRanks’ Stock Analysis page.

